Norway a World Leader in Childhood Diabetes Care

The Norwegian Childhood Diabetes Registry

Photo: pexels.com

Norway has achieved world-leading results in the treatment of children with type 1 diabetes, according to new data from the Norwegian Childhood Diabetes Registry.

In 2025, the national average HbA1c level among children dropped to 50.5 mmol/mol, the lowest ever recorded, placing Norway ahead of other countries in terms of treatment outcomes.

At the same time, the incidence of type 1 diabetes continues to rise, with 440 children diagnosed last year. Good glycemic control is crucial to reducing the risk of serious long-term complications.

“We are now achieving results that I previously did not think were possible,” said Professor, MD, Torild Skrivarhaug, Head of The Norwegian Childhood Diabetes Registry.

The improvements are attributed to technological advances, such as continuous glucose monitoring and insulin pumps, as well as sustained efforts by pediatric diabetes teams across Norway. These efforts include a continuous focus on quality improvement and a dynamic way to set treatment targets.

Health Minister Jan Christian Vestre described the results as “world-class” and praised the healthcare services for their work.

Oslo Diabetes Research Centre congratulates the Norwegian Childhood Diabetes Registry, and the clinical and research communities on these outstanding results.

Read the original article here (TV 2, Norwegian).